What is Immunome's prepaid & other current?

Immunome (IMNM) reported prepaid & other current of $11.62M in Q1 2026.

How has Immunome's prepaid & other current changed year-over-year?

Immunome's prepaid & other current increased by 100.0% year-over-year, from $5.81M to $11.62M.

What is the long-term trend for Immunome's prepaid & other current?

Over 4 years (2021 to 2025), Immunome's prepaid & other current has grown at a 10.2% compound annual growth rate (CAGR), from $20.17M to $29.78M.

What does prepaid & other current mean?

Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Immunome IMNM Prepaid & Other Current

Prepaid & Other Current at other companies

SELLAS Life Sciences Group, Inc.SLS

$3.97M+14.3%

IDEAYA Biosciences, Inc.IDYA

$18.35M+19.4%

Summit TherapeuticsSMMT

$17.55M+92.5%

Immunovant, Inc.IMVT

$42.76M-16.4%

ExelixisEXEL

$75.88M+29.3%

Nektar TherapeuticsNKTR

$20.44M+81.2%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's prepaid & other current?: Immunome (IMNM) reported prepaid & other current of $11.62M in Q1 2026.
How has Immunome's prepaid & other current changed year-over-year?: Immunome's prepaid & other current increased by 100.0% year-over-year, from $5.81M to $11.62M.
What is the long-term trend for Immunome's prepaid & other current?: Over 4 years (2021 to 2025), Immunome's prepaid & other current has grown at a 10.2% compound annual growth rate (CAGR), from $20.17M to $29.78M.
What does prepaid & other current mean?: Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.